Literature DB >> 29911817

Commentary - Building the evidence base for sustained public health response to the opioid epidemic in Canada.

Theresa Tam1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29911817      PMCID： PMC6034972          DOI： 10.24095/hpcdp.38.6.01

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN： 2368-738X            Impact factor:   3.240


× No keyword cloud information.
  7 in total

1.  Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study.

Authors:  Heather M Orpana; Justin J Lang; Maulik Baxi; Jessica Halverson; Nicole Kozloff; Leah Cahill; Samiah Alam; Scott Patten; Howard Morrison
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

Review 2.  The opioid crisis in Canada: a national perspective.

Authors:  Lisa Belzak; Jessica Halverson
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

3.  At-a-glance - What can social media tell us about the opioid crisis in Canada?

Authors:  Semra Tibebu; Vicky C Chang; Charles-Antoine Drouin; Wendy Thompson; Minh T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

4.  At-a-glance - Hospitalizations and emergency department visits due to opioid poisoning in Canada.

Authors:  Shannon O'Connor; Vera Grywacheski; Krista Louie
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

5.  At-a-glance - Impact of drug overdose-related deaths on life expectancy at birth in British Columbia.

Authors:  Xibiao Ye; Jenny Sutherland; Bonnie Henry; Mark Tyndall; Perry Robert William Kendall
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

6.  Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.

Authors:  Qi Guan; Wayne Khuu; Diana Martins; Mina Tadrous; Maria Chiu; Minh T Do; Tara Gomes
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

7.  At-a-glance - Lessons learned from launching the Manitoba Take-Home Naloxone Program.

Authors:  Songul Bozat-Emre; Shelley G Marshall; Colin Zhong; Joss Reimer
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240
  7 in total
  2 in total

Review 1.  Development of vaccines to treat opioid use disorders and reduce incidence of overdose.

Authors:  Marco Pravetoni; Sandra D Comer
Journal:  Neuropharmacology       Date:  2019-06-04       Impact factor: 5.250

2.  Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.

Authors:  Federico Baruffaldi; April Huseby Kelcher; Megan Laudenbach; Valeria Gradinati; Ajinkya Limkar; Michaela Roslawski; Angela Birnbaum; Andrew Lees; Carla Hassler; Scott Runyon; Marco Pravetoni
Journal:  Mol Pharm       Date:  2018-10-10       Impact factor: 4.939
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.